Daniel Collins v. Unum Life Ins. Co. of America

682 F. App'x 381
CourtCourt of Appeals for the Sixth Circuit
DecidedMarch 9, 2017
DocketCase 16-3918
StatusUnpublished
Cited by2 cases

This text of 682 F. App'x 381 (Daniel Collins v. Unum Life Ins. Co. of America) is published on Counsel Stack Legal Research, covering Court of Appeals for the Sixth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Daniel Collins v. Unum Life Ins. Co. of America, 682 F. App'x 381 (6th Cir. 2017).

Opinion

OPINION

BERNICE BOUIE DONALD, Circuit Judge.

Almost a year after Daniel Collins fell in his employer’s parking lot, fracturing his ankle, his foot was amputated. Pointing to Collins’ long history of diabetes and medical evidence suggesting that it led to the severity of Collins’ injury, Unum Life Insurance Company, the administrator of Collins’ ERISA plan, denied Collins’ claim for benefits under an exclusion precluding from coverage losses caused in any way by a disease or illness. We conclude that Unum’s medical expert based its decision on a view of the entire record and that the decision to deny Collins’ benefits is supported by substantial evidence, notwithstanding Unum’s inherent conflict of interest. Accordingly, we AFFIRM the district court’s decision to uphold the benefits denial and deny Collins additional discovery.

I.

Collins was an employee of Affymetrix, Inc. On January 6, 2012, Collins slipped and fell while walking in Asymetrix's parking lot, injuring his foot. His foot was amputated around February 8, 2013. Prior to his injury and through the date of his amputation, reports from treating physicians indicated that Collins had a history of poorly maintained diabetes.

Dr. Wissam Khoury, Collins’ treating podiatrist, examined Collins multiple times after his initial injury, including during several procedures conducted in late 2012 to attempt to salvage his foot, and during the eventual amputation in 2013. During this time period Dr. Khoury’s reports often noted Collins’ longstanding history with diabetes. His- assessments also associate Collins’ Charcot ankle—a condition resulting in neuropathy, or loss of sensation—with his diabetes and diabetic neu-ropathy. Importantly, Dr. Khoury’s pre- and post-operative diagnoses for the limb-salvaging procedures and the amputation include diabetes with diabetic neuropathy, alongside other conditions like trimalleolar ankle fracture, Charcot neuroarthropathy, and osteomyelitis—a bone infection.

Another podiatrist, Dr. Anthony Polito, assessed Collins with diabetic sensory neu-ropathy after Collins presented to him “for diabetic foot care.” Administrative R. 13-2, Page ID 612. Though Collins showed no signs of infection from February until May 2012, Dr. Polito consistently reported diabetic sensory neuropathy as an objective symptom.

Dr. Mark Berkowitz, another of Collins’ treating physicians, noted in a report signed on February 12, 2013, that Collins was transferred to the hospital for “chronic right ankle and distal tibial osteomyeli-tis,” and a “Charcot ankle fracture.” Administrative R., ECF No. 13-1, Page ID 277. Collins was then counselled about the *384 risks and benefits of an amputation, and was transferred to the operating room for that procedure.

Afterwards, Collins sought benefits under the select group insurance trust policy (the “Plan”), which is administered by Unum and governed by ERISA. Unum both determines eligibility for and pays benefits under the Plan. The Plan contains an exclusion for “accidental losses caused by, contributed to by, or resulting from ... disease of the body.” 1 Id. at Page ID 180.

In a follow-up visit on March 5, 2013, Dr. Berkowitz’s notes listed Collins’ diagnoses of diabetes mellitus and type 2 diabetes mellitus, the latter of which was “poorfly] controlled].” Id. at Page ID 281-83. On a form from Unum dated March 14, 2013, Dr. Berkowitz again noted Collins’ diagnosis of “charcot arthropathy” and “chronic osteomyelitis.” Id. at Page ID 127. Additionally, he circled “No” in response to Unum’s inquiry of whether he thought “the loss [was] caused in any way by illness or disease.” Id. He did not provide any further explanation.

Unum pathologist Kristin Sweeney was asked to determine the extent, if any, a disease of the body contributed to Collins’ loss. In a report dated July 10, 2013, she noted Collins’ injuries and diabetes diagnosis and observed that “diabetics have more complications with trimalleolar fractures.” Id. at Page ID 405-07. While not opining on whether diabetes played any role in Collins’ amputation, Sweeney concluded that due to the limited records available, she could not “determine the degree to which diabetes mellitus may have contributed to Mr. Collins’ complications.” Id. at Page ID 407 (emphasis added). As a result, clinical consultant Marnie Webb, noting her discussion with Dr. Sweeney that diabetes can contribute significantly to complications arising from ankle fractures, requested additional records that would be needed to determine the degree, if at all, diabetes led to Collins’ loss.

Another Unum pathologist, Dr. Barbara Golder, was also asked to determine to extent, if any, a disease of the body contributed to Collins’ loss. In a report dated November 19, 2013, after asserting that she reviewed all medical and clinical evidence provided to her, Dr. Golder concluded as follows;

This insured has a history of diabetes for many years as well as morbid obesity. It is unclear from the records to what degree he had a pre-existing, diagnosed neuropathy in the affected leg but the presence of diabetes and the notation that it was at least intermittently difficult to control makes it likely that there is at least a degree of pre-existing neuropathy. Charcot joints develop only in the presence of neuropathy, which may be the result of diabetes, or other illness such as post-chemotherapy, syphilis or leprosy. It is usually triggered by trauma, often insignificant. To a reasonable degree of medical certainty, without the presence of underlying diabetes (or another source of neuropathy), this insured would not have developed a Charcot joint. Further, his course was complicated by the seriousness of the fracture which, despite immediate and appropriate care, did not resolve; he also developed chronic osteomyelitis. Increased risk of infection is also a characteristic of diabetes. It was the failure of treatment and the presence of osteo- *385 myelitis that led to the amputation of the foot.
Conversely, this was a serious, debilitating injury and from the record it was clearly the trigger for the development of the Charcot joint as that was not present prior to the injury. To a reasonable degree of medical certainty, but for the anide fracture, this insured would not have developed a Charcot joint at this time and might never have. To a reasonable degree of medical certainty both the underlying illness and the injury were necessary for the development of the joint pathology that led to amputation.

Administrative R. 13-2, Page ID 807.

In a letter dated November 21, 2013, Unum denied Collins’ claim for benefits, concluding that his loss was contributed to by his diabetes, thus barring him from coverage under the provision excluding from coverage any “accidental losses caused by, contributed to by, or resulting from ... disease of the body.” Administrative R., ECF No. 13-1, Page ID 810-11.

Collins filed a complaint in Ohio state court arguing he was entitled to benefits under 29 U.S.C. § 1132(a)(1)(B).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
682 F. App'x 381, Counsel Stack Legal Research, https://law.counselstack.com/opinion/daniel-collins-v-unum-life-ins-co-of-america-ca6-2017.